Anterix vs Veon
Veon reported revenue of $4.4 billion in fiscal 2025, 676.8 times Anterix's $6 million in fiscal 2026. Anterix's revenue grew 7.8% in its latest year, and Veon's grew 9.9%. Anterix had an operating margin of 1444.8%, against 32.7% at Veon. Their fiscal years end in different months (March 31 and December 31), so the periods don't line up exactly.
Side by side
| Anterix | Veon | |
|---|---|---|
| Latest fiscal year | FY2026, Mar 31, 2026 | FY2025, Dec 31, 2025 |
| Revenue | $6M | $4.4B |
| Revenue growth | 7.8% | 9.9% |
| Revenue growth a year, last 5 years | 48.5% | 4.8% |
| Gross margin | — | — |
| Operating margin | 1,444.8% | 32.7% |
| Net margin | 1,394.2% | 13.4% |
| Free cash flow | $5M | — |
| Free cash flow margin | 84.3% | — |
| Return on capital | — | 36.4% |
| Net debt to EBITDA | — | 0.6x |
| Dividends and buybacks | $1M | $172M |
| Change in diluted share count | 1.0% | −0.9% |
| Last close | $74.36 | $77.57 |
| P/E at the last close | 21.2× | — |
| Insider trades, last 12 months | — | bought $1.1 million, sold $0 |
| Piotroski F-score | — | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
AnterixVeon
Operating margin
Percent of revenue
AnterixVeon
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
AnterixVeon